Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling